Aryastha was established with the purpose of tackling the common challenges faced by pharmaceutical and biotechnology industries throughout the discovery and developing new drugs.
Aryastha stands as the culmination of their transformative journey, spanning multiple years, in addressing scientific challenges across diverse verticals of drug discovery and development. It has evolved into an integrated one-stop-shop solution, embodying their collective expertise and experience. We are uniquely positioned to provide enhanced agility and flexibility in serving our clients, enabling us to expedite the delivery of life-changing medicines to the market.
Our Values
RISE^ C4
Our core values can be summarized in RISE^C4 which stands for Respect, Innovation, Success, Evolution, Confidentiality, Collective Care and Commitment. These values define our organizational culture, guide our actions and propel us towards excellence and lasting success.
Vision
Aryastha was established to tackle the common challenges faced by pharmaceutical and biotechnology industries throughout the discovery and development of new drugs. Aryastha is the culmination of their transformative journey, spanning multiple years, in addressing scientific challenges across diverse drug discovery and development verticals. It has evolved into an integrated one-stop-shop solution, embodying their expertise and experience. We are uniquely positioned to provide enhanced agility and flexibility in serving our clients, enabling us to expedite the delivery of life-changing medicines to the market.
Our Mission
Our mission is to provide innovative and integrated solutions that de-risk and streamline drug discovery and development, driving toward a healthier future. We are committed to add value by understanding the unique needs of our clients, collaborating with global Biotech and Pharmaceutical partners, and leveraging our capabilities to fuel advancements in healthcare.
Our Strategy
Our strategy is to continuously enhance our capabilities and adapt to the evolving landscape of the Biotech and Pharmaceutical industry. Investing in cutting-edge technologies and relentlessly pursuing higher quality and better efficiency. We drive innovative and transformative drug discovery and development breakthroughs by prioritizing collaboration and nurturing employee growth.
Our Leadership
Aryastha is propelled forward by a cadre of highly experienced and exceptionally talented leaders who have spearheaded over 75 integrated programs, successfully ushered 11 Investigational New Drug applications (INDs), and orchestrated the development of 6 clinical assets spanning the phases of I, II, and III.
Dr. Raghava Reddy Kethiri, Ph.D
Chief Executive Officer
Ms. Laura Z. Sailor
Chief Business Officer
Dr. Ram S. Upadhayaya, Ph.D, D.Sc.
Chief Technology Officer
Dr. Biswanath Majumder, Ph.D
Associate Vice President
Translational Biology
Dr. Ansar Ali Khan, Ph.D
Director and Head, DMPK
Our Scientific Advisory Board
Dr. Pradip K. Majumder, Ph.D
Chief Scientific Advisor
Dr. Gnaneswar Atturu, MD
Chief Clinical Advisor
